Patients, and families of patients, impacted by advanced melanoma are invited to participate in an online interview to explore their views, experiences, and needs related to genetic information, support and testing.
Hosted by MIA in Sydney, AMC2024 brought together 776 multidisciplinary delegates to engage in insightful discussions, presentations and workshops, all dedicated to reaching our common goal of zero deaths from melanoma. See our AMC2024 photo album.
This World Cancer Research Day, the NSW Government is committing $2.1 million in research grant funding, with almost $700k awarded to MIA's Prof Long for an imaging system that will allow researchers to better visualise & understand tumour cell interactions.
MIA’s leading experts and early career researchers have shared the world stage at the annual European Society for Medical Oncology (ESMO) Congress in Barcelona.
Final results of the COMBI-AD clinical trial, published in New England Journal of Medicine, show significant benefit in preventing disease progression in BRAF positive Stage III melanoma patients.
In what has been described as a cancer treatment revolution, the pre-surgery use of combination immunotherapy looks to become standard treatment for melanoma and impact other cancers across the globe.
Congratulations to Professor Georgina Long AO, elected as a Fellow of the Australian Academy of Science in recognition of her outstanding contribution to science.
Listen to Profs Long and Scolyer on ABC Radio Sydney for an update on Richard's #braincancer journey & recent results. how melanoma science is being used to treat his #glioblastoma. Budget funding news and their Australian of the Year activities.
The federal government has announced a new immunotherapy treatment for advanced melanoma patients has been added to PBS, significantly reducing the cost of the life-saving treatment.
We are delighted to have been successful in receiving four research grants recently awarded by Tour de Cure Australia.
